About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

EU High Representative for Foreign Affairs and Security Policy Kallas: Regarding the new sanctions against Russia, the most important thing is the oil price cap.

2025-05-21

EU High Representative for Foreign Affairs and Security Policy Kallas: Regarding the new sanctions against Russia, the most important thing is the oil price cap.

Other News
2025-05-20

Ministry of Finance: From January to April, the national general public budget revenue was 8061.6 billion yuan, a year-on-year decrease of 0.4%. Among them, the national tax revenue was 6555.6 billion yuan, a year-on-year decrease of 2.1%; non-tax re

Ministry of Finance: From January to April, the national general public budget revenue was 8061.6 billion yuan, a year-on-year decrease of 0.4%. Among them, the national tax revenue was 6555.6 billion yuan, a year-on-year decrease of 2.1%; non-tax revenue was 1506.0 billion yuan, a year-on-year increase of 7.7%. Stamp tax was 161.4 billion yuan, a year-on-year increase of 18.9%. Among them, the stamp tax on securities transactions was 53.5 billion yuan, a year-on-year increase of 57.8%.
2025-05-21

Hong Kong-listed pharmaceutical stocks continued to be strong, with CanSino Biologics (06185.HK) rising more than 10%, Junshi Biosciences (01877.HK) rising more than 9%, and Clover Biopharmaceuticals (02197.HK) and Akeso Biopharmaceuticals (09926.HK)

Hong Kong-listed pharmaceutical stocks continued to be strong, with CanSino Biologics (06185.HK) rising more than 10%, Junshi Biosciences (01877.HK) rising more than 9%, and Clover Biopharmaceuticals (02197.HK) and Akeso Biopharmaceuticals (09926.HK) following suit.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2025 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.

Web Design by YSD